Home Cart 0 Sign in  
X

[ CAS No. 5933-40-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5933-40-4
Chemical Structure| 5933-40-4
Chemical Structure| 5933-40-4
Structure of 5933-40-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5933-40-4 ]

Related Doc. of [ 5933-40-4 ]

Alternatived Products of [ 5933-40-4 ]

Product Details of [ 5933-40-4 ]

CAS No. :5933-40-4 MDL No. :MFCD00044966
Formula : C9H13N Boiling Point : -
Linear Structure Formula :- InChI Key :RCSSHZGQHHEHPZ-MRVPVSSYSA-N
M.W : 135.21 Pubchem ID :2060888
Synonyms :

Calculated chemistry of [ 5933-40-4 ]

Physicochemical Properties

Num. heavy atoms : 10
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.33
Num. rotatable bonds : 2
Num. H-bond acceptors : 1.0
Num. H-bond donors : 1.0
Molar Refractivity : 43.82
TPSA : 12.03 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.92 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.24
Log Po/w (XLOGP3) : 1.69
Log Po/w (WLOGP) : 1.64
Log Po/w (MLOGP) : 2.19
Log Po/w (SILICOS-IT) : 2.01
Consensus Log Po/w : 1.95

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.05
Solubility : 1.19 mg/ml ; 0.00881 mol/l
Class : Soluble
Log S (Ali) : -1.56
Solubility : 3.75 mg/ml ; 0.0277 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -3.24
Solubility : 0.078 mg/ml ; 0.000577 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.0

Safety of [ 5933-40-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P301+P312-P302+P352-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5933-40-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 5933-40-4 ]

[ 5933-40-4 ] Synthesis Path-Downstream   1~88

  • 1
  • [ 5933-40-4 ]
  • [ 123-38-6 ]
  • [ 25654-39-1 ]
  • 2
  • [ 5933-40-4 ]
  • [ 106-93-4 ]
  • [ 71918-53-1 ]
  • 3
  • [ 3886-69-9 ]
  • [ 2258-42-6 ]
  • [ 5933-40-4 ]
  • 4
  • [ 104785-55-9 ]
  • [ 5933-40-4 ]
  • 11R-3-(N-methyl-N-α-methylbenzyl)carbamoyl-2,4-dimethylquinoline [ No CAS ]
  • 5
  • [ 6948-01-2 ]
  • [ 5933-40-4 ]
  • 6
  • [ 51760-23-7 ]
  • [ 124-41-4 ]
  • [ 5933-40-4 ]
  • (-)-5-Brom-1-((N-methyl-1'-phenylethylaminomethyl)-3-methyloxymethyl)benzol [ No CAS ]
  • 7
  • [ 51760-23-7 ]
  • [ 5933-40-4 ]
  • (-)-5-Brom-1,3-di<(N-methyl-1'-phenylethyl)aminomethyl>benzol [ No CAS ]
  • 8
  • [ 2004-06-0 ]
  • [ 5933-40-4 ]
  • [ 97826-58-9 ]
  • 10
  • [ 5933-40-4 ]
  • [ 92686-73-2 ]
  • [ 126745-09-3 ]
  • 11
  • [ 5933-40-4 ]
  • [ 1011534-42-1 ]
  • [ 89362-13-0 ]
  • 12
  • [ 5933-40-4 ]
  • [ 1011534-42-1 ]
  • [ 114351-92-7 ]
  • 13
  • [ 5933-40-4 ]
  • (S)-quinuclidine-2-carboxylic acid hydrochloride [ No CAS ]
  • (S)-N-methyl-N-<(R)-1-phenylethyl>-2-quinuclidinecarboxamide [ No CAS ]
  • 14
  • [ 6948-01-2 ]
  • [ 5933-40-4 ]
YieldReaction ConditionsOperation in experiment
With lithium aluminium tetrahydride; In tetrahydrofuran; at 0℃; for 4.5h;Reflux; Inert atmosphere; To a THF (50 mL) suspension of lithium aluminum hydride (4.24 g, 112 mmol), a THF (50 mL) solution of crude (R)-4 was added dropwise at 0 C. After the reaction mixture was refluxed for 4.5 h, water and Et2O were added to the mixture and the resulting precipitate was removed by suction filtration. The filtrate was washed with water and brine, and dried over anhydrous Na2SO4 and anhydrous Na2CO3. After removal of the solvent under reduced pressure, crude (R)-N-methyl-1-phenylethylamine (5) was obtained and used in the next step without further purification.
  • 15
  • [ 5933-40-4 ]
  • [ 75-03-6 ]
  • C13H22N(1+)*CN(1-) [ No CAS ]
  • 16
  • [ 5933-40-4 ]
  • [ 2114-00-3 ]
  • [ 87258-69-3 ]
  • 17
  • ((R)-1-Phenyl-ethyl)-[2,2,2-triphenyl-eth-(E)-ylidene]-amine [ No CAS ]
  • [ 519-73-3 ]
  • [ 5933-40-4 ]
  • 18
  • [ 5933-40-4 ]
  • [ 2155-96-6 ]
  • (2-Diphenylphosphanyl-ethyl)-methyl-(1-phenyl-ethyl)-amine [ No CAS ]
  • 19
  • [ 5933-40-4 ]
  • [ 2155-96-6 ]
  • (2-Diphenylphosphanyl-ethyl)-methyl-(1-phenyl-ethyl)-amine [ No CAS ]
  • 20
  • [ 5933-40-4 ]
  • [ 1484-50-0 ]
  • [ 87258-81-9 ]
  • 21
  • [ 75-16-1 ]
  • [ 29843-09-2 ]
  • [ 5933-40-4 ]
  • 22
  • [ 106967-42-4 ]
  • [ 5933-40-4 ]
  • (+)-4-brom-2,6-bis(N-methyl-N-1'-phenylethylaminomethyl)pyridin [ No CAS ]
  • 23
  • [ 5933-40-4 ]
  • [ 68-12-2 ]
  • [ 2032-35-1 ]
  • (S)-(1,2-dihydro-1,2-dimethyl-3-isoquinolyl)methanol [ No CAS ]
  • (R)-(1,2-dihydro-1,2-dimethyl-3-isoquinolyl)methanol [ No CAS ]
  • 25
  • [ 13734-34-4 ]
  • [ 5933-40-4 ]
  • [ 154812-25-6 ]
  • 26
  • [ 5933-40-4 ]
  • [ 81838-85-9 ]
  • (E)-(R)-3-[Methyl-((R)-1-phenyl-ethyl)-amino]-hex-4-enoic acid tert-butyl ester [ No CAS ]
  • [ 177329-62-3 ]
  • 27
  • [ 79-03-8 ]
  • [ 5933-40-4 ]
  • [ 184883-06-5 ]
  • 28
  • [ 5933-40-4 ]
  • (R,R)-bis[2-[1-(methylamino)ethyl]phenyl] diselenide [ No CAS ]
  • 29
  • [ 5933-40-4 ]
  • [ 191475-25-9 ]
  • [ 191475-29-3 ]
  • 30
  • [ 5933-40-4 ]
  • [ 191475-26-0 ]
  • [ 191475-30-6 ]
  • 31
  • [ 5933-40-4 ]
  • [ 191475-27-1 ]
  • [ 191475-31-7 ]
  • 32
  • [ 5933-40-4 ]
  • [ 191475-28-2 ]
  • [ 191475-32-8 ]
  • 33
  • [ 402-43-7 ]
  • [ 5933-40-4 ]
  • Methyl-((R)-1-phenyl-ethyl)-(4-trifluoromethyl-phenyl)-amine [ No CAS ]
  • 34
  • [ 96517-97-4 ]
  • [ 5933-40-4 ]
  • Methyl-(6'-[methyl-((R)-1-phenyl-ethyl)-amino]-methyl}-[2,2']bipyridinyl-6-ylmethyl)-((R)-1-phenyl-ethyl)-amine [ No CAS ]
  • 35
  • [ 5933-40-4 ]
  • [ 167082-58-8 ]
  • [ 195061-59-7 ]
  • 36
  • [ 5933-40-4 ]
  • [ 200068-20-8 ]
  • (2-Chloro-6-[methyl-((R)-1-phenyl-ethyl)-amino]-methyl}-quinolin-3-ylmethyl)-methyl-((R)-1-phenyl-ethyl)-amine [ No CAS ]
  • 37
  • [ 5933-40-4 ]
  • [ 1218-34-4 ]
  • (S)-2-Acetylamino-3-(1H-indol-3-yl)-N-methyl-N-((R)-1-phenyl-ethyl)-propionamide [ No CAS ]
  • 38
  • [ 5933-40-4 ]
  • [ 7432-21-5 ]
  • {(S)-2-(1H-Indol-3-yl)-1-[methyl-((R)-1-phenyl-ethyl)-carbamoyl]-ethyl}-carbamic acid benzyl ester [ No CAS ]
  • 40
  • [ 63501-27-9 ]
  • [ 5933-40-4 ]
  • Methyl-((R)-2-methyl-pent-4-enyl)-((R)-1-phenyl-ethyl)-amine [ No CAS ]
  • 41
  • [ 2684-62-0 ]
  • [ 5933-40-4 ]
  • 1-[Methyl-((R)-1-phenyl-ethyl)-amino]-propan-2-one [ No CAS ]
  • 44
  • [ 5933-40-4 ]
  • [ 145178-53-6 ]
  • [ 300809-98-7 ]
  • 45
  • [ 16712-16-6 ]
  • [ 5933-40-4 ]
  • (R)-N-methyl-N-(1-phenylethyl)formamide [ No CAS ]
  • 47
  • [ 5933-40-4 ]
  • [ 103-72-0 ]
  • 1-Methyl-3-phenyl-1-((R)-1-phenyl-ethyl)-thiourea [ No CAS ]
  • 48
  • [ 5933-40-4 ]
  • poly((S)-glycidyl methacrylate-co-ethylene glycol dimethacrylate), radical suspension copolymerizaiton, particles size: 87 percent 106 - 300 μm and 13 percent 300 - 500 μm; monomers: (S)-glycidyl methacrylate; ethylene glycol dimethacrylate, 70 wt percent [ No CAS ]
  • poly((2S)-3-[(R)-methyl(1-phenylethyl)amino]-2-hydroxypropyl methacrylate-co-ethylene glycol dimethacrylate), amino alcohol function - 59 percent; monomers: (S)-glycidyl methacrylate; ethylene glycol dimethacrylate, 70 wt percent; (R)-N,α-dimethylbenzylamine [ No CAS ]
  • 49
  • Merrifield\ss peptide resin-(CH2)-bound -O-C(O)-NH-(R)-CHMe(Ph) [ No CAS ]
  • [ 5933-40-4 ]
  • 50
  • [ 5933-40-4 ]
  • [ 303165-21-1 ]
  • (3,4-Bis-difluoromethoxy-phenyl)-{6-[methyl-((R)-1-phenyl-ethyl)-amino]-pyridin-3-yl}-methanone [ No CAS ]
  • 51
  • [ 49566-72-5 ]
  • [ 5933-40-4 ]
  • [ 592527-36-1 ]
  • 52
  • [ 38274-14-5 ]
  • [ 5933-40-4 ]
  • 6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 53
  • [ 5933-40-4 ]
  • [ 139253-13-7 ]
  • 4,8-dibromo-2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 54
  • [ 5933-40-4 ]
  • [ 39648-74-3 ]
  • (R)-N-methyl-N-1-phenylethyl-(S)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthyl phosphoramidite [ No CAS ]
  • 55
  • [ 5933-40-4 ]
  • [ 600172-57-4 ]
  • 2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-6-methyl-4,8-diphenyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 56
  • [ 5933-40-4 ]
  • [ 600172-58-5 ]
  • 2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-4,8-bis-(4-methoxy-phenyl)-6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 57
  • [ 5933-40-4 ]
  • C44H44Br2O2 [ No CAS ]
  • 2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-6-methyl-4,8-di-naphthalen-2-yl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 58
  • [ 5933-40-4 ]
  • [ 600172-59-6 ]
  • 2,10-di-<i>tert</i>-butyl-4,8-bis-(4-<i>tert</i>-butyl-phenyl)-3,9-dimethoxy-6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 59
  • [ 5933-40-4 ]
  • [ 600172-60-9 ]
  • 4,8-bis-biphenyl-4-yl-2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 60
  • [ 5933-40-4 ]
  • 2,2'-Bis-bromomethyl-3,3'-bis-(3,5-(trifluoromethyl)phenyl)-5,5'-di-tert-butyl-4,4'-dimethoxy-1,1'-biphenyl [ No CAS ]
  • 4,8-bis-(3,5-bis-trifluoromethyl-phenyl)-2,10-di-<i>tert</i>-butyl-3,9-dimethoxy-6-methyl-6-(1-phenyl-ethyl)-6,7-dihydro-5<i>H</i>-dibenzo[<i>c</i>,<i>e</i>]azepinium; bromide [ No CAS ]
  • 61
  • [ 5933-40-4 ]
  • [ 209398-27-6 ]
  • ((S)-1-{Hydroxy-[methyl-((R)-1-phenyl-ethyl)-carbamoyl]-methyl}-pentyl)-carbamic acid tert-butyl ester [ No CAS ]
  • 62
  • [ 5933-40-4 ]
  • [ 1885-14-9 ]
  • Methyl-((R)-1-phenyl-ethyl)-carbamic acid phenyl ester [ No CAS ]
  • 63
  • 4,<i>N</i>-dimethyl-<i>N</i>-(1-phenyl-ethyl)-benzenesulfonamide [ No CAS ]
  • [ 5933-40-4 ]
  • 64
  • [ 681440-00-6 ]
  • [ 5933-40-4 ]
  • 65
  • [ 5933-40-4 ]
  • (M)-2-bromomethyl-1-(4',6'-dimethyl-2'-(diphenylphosphinyl)phenyl)naphthalene [ No CAS ]
  • {1-[2-(Diphenyl-phosphinoyl)-4,6-dimethyl-phenyl]-naphthalen-2-ylmethyl}-methyl-((R)-1-phenyl-ethyl)-amine [ No CAS ]
  • 66
  • [ 5933-40-4 ]
  • (M)-2-bromomethyl-1-(4',6'-dimethoxy-2'-(diphenylphosphinyl)phenyl)naphthalene [ No CAS ]
  • {1-[2-(Diphenyl-phosphinoyl)-4,6-dimethoxy-phenyl]-naphthalen-2-ylmethyl}-methyl-((R)-1-phenyl-ethyl)-amine [ No CAS ]
  • 67
  • [ 10557-01-4 ]
  • [ 19131-99-8 ]
  • [ 5933-40-4 ]
YieldReaction ConditionsOperation in experiment
With formic acid; bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; triethylamine; (R,R)-N-(p-toluenesulfonyl)-1,2-diphenylethylenediamine; at 40℃; for 2h;Inert atmosphere; To a nitrogen-purged flask was added (E)-N-(alpha-methylbenzylidene)methylamine (135 mg, 1 mmol), [IrCp*Cl2]2 (4 mg, 0.005 mmol), (R,R)-TsDPEN (4 mg, 0.01 mmol). To this mixture was then added formic acid/triethylamine 5:2 (1 mL). The reaction mixture was stirred under nitrogen at 40 C for 2 hours. Following this the reaction solution was filtered through silica (1:1 EtOAc/petroleum ether40-60) and the resulting solution dried by rotary evaporation to leave the crude product as a paleyellow oil. The crude was analysed by chiral GC to confirm formation of the product and to determineconversion and enantiomeric excess. GC method: CP-Chirasil-Dex-CB, 25 m 0.25 mm, 0.25 mum. H2 7.5 psi, injector 250 C, FID 250 C,oven: 80 C hold 1 min, 100 C/min to 100 C, 13 min hold, 100 C/min to 200 C, 5 min hold. (R)-amine 16.6 min. (S)-amine 17.1 min.
  • 68
  • [ 38002-45-8 ]
  • [ 5933-40-4 ]
  • Methyl-((R)-1-phenyl-ethyl)-(3-trimethylsilanyl-prop-2-ynyl)-amine [ No CAS ]
  • 69
  • [ 367965-70-6 ]
  • [ 5933-40-4 ]
  • [ 478555-34-9 ]
  • 70
  • [ 867061-98-1 ]
  • [ 5933-40-4 ]
  • 1<i>H</i>-imidazole-4,5-dicarboxylic acid 5-[(3,4-dichloro-phenyl)-amide] 4-[methyl-(1-phenyl-ethyl)-amide] [ No CAS ]
  • 71
  • [ 142653-49-4 ]
  • [ 5933-40-4 ]
  • 2-(5,7-dimethyl-2-phenyl-pyrazolo[1,5-<i>a</i>]pyrimidin-3-yl)-<i>N</i>-methyl-<i>N</i>-(1-phenyl-ethyl)-acetamide [ No CAS ]
  • 72
  • [ 840454-59-3 ]
  • [ 5933-40-4 ]
  • (1R,7R)-4-(N-methyl-N-(R)-1-phenylethylamino)-9,9-dimethyl-2,2,6,6-tetra(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane [ No CAS ]
  • 73
  • [ 840505-84-2 ]
  • [ 5933-40-4 ]
  • (1S,7S)-4-(N-methyl-N-(R)-1-phenylethylamino)-9,9-dimethyl-2,2,6,6-tetra(3,5-dimethylphenyl)-3,5,8,10-tetraoxa-4-phosphabicyclo[5.3.0]decane [ No CAS ]
  • 74
  • [ 5933-40-4 ]
  • (R)-3,3'-bis(trimethylsilyl)-2,2'-binaphthol phosphorochloridite [ No CAS ]
  • (R)-O,O'-(1,1'-dinaphthyl-2,2'-diyl-3,3'-di(trimethylsilyl))-N-methyl-N-(R)-1-phenylethylphosphoramidite [ No CAS ]
  • 75
  • [ 1564-64-3 ]
  • [ 5933-40-4 ]
  • [ 944548-46-3 ]
  • 77
  • [ 873075-58-2 ]
  • [ 5933-40-4 ]
  • 1,1-dimethylethyl 4-[5-[[methyl[(1R)-1-phenylethyl]amino]-carbonyl]-2-thiazolyl]-1-piperazinecarboxylate [ No CAS ]
YieldReaction ConditionsOperation in experiment
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; Step C: Preparation of 1,1-dimethylethyl 4-[5-[[memyl[(1R)-1-phenylethyl]amino}-carbonyl]-2-thiazolyl]-1-piperazinecarboxylate. 1-(1,1-Dimethylethyl) 4-(5-carboxy-2-thiazolyl)-l-piperazinecarboxylate (i.e. the product of Example 4, Step B) (1.0 g, 3.2 mmol,) was suspended in 10 mL of dry acetonitrile and treated with triethylamine (892 mL, 6.4 mmol) to give a homogeneous solution. To this was added (O-benzotriazoI-1-yI-N,N,N',N'-tetramethyluronium hexafluorophosphate (1.33 g, 3.5 mmol) followed by (alphaR)-Nalpha-dimethylbenzenemethanamine (i.e. the product of Example 1, Step C) (200 mL, 1.38 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give 1.38 g of an orange foam. Purification by silica gel chromatography using an ethyl acetate/hexanes gradient from 1:9 to 100:0 gave 0.78 g of the title compound as a yellow solid. 1H NMR (CDCl3) delta 1.48 (s, 9H), 1.6 (m, 3H), 2.88 (s, 3H), 3.54 (br m, 8H), 5.9 (m, IH), 7.25-7.45 (m, 5H), 7.47 (s, IH).
  • 78
  • [ 365413-00-9 ]
  • [ 5933-40-4 ]
  • [ 922516-01-6 ]
YieldReaction ConditionsOperation in experiment
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; 1-(1,1-Dimethylethyl) 4-(4-carboxy-2-thiazolyl)-l-piperidinecarboxylate (i.e. the product of Example 1, Step B) (6.86 g, 21.96 mmol) was suspended in 30 mL of dry acetonitrile and treated with triethylamine (6.12 mL, 43.92 mmol) to give a homogeneous solution. To this was added O-benzotriazol-l-yl-N,/V,N',N'-tetramethyluronium hexafluorophosphate (9.16 g, 24.16 mmol) followed by methanamine (3.19 mL, 21.96 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give a dark oil. Purification by silica gel chromatography using 25-100 % ethyl acetate in hexanes as eluant gave 9.12 g of the title compound as an oil.1H NMR (CDCl3) delta 1.46 (s, 9H), 1.6-1.8 (m, 5H), 2.0-2.2 (m, 2H), 2.7-3.0 (m, 5H), 3.15 (m, IH), 4.15 (m, 2H), 5.7-6.2 (m, IH), 7.25-7.45 (m, 5H), 7.81 (s, IH).
With O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; triethylamine; In acetonitrile; at 20℃; for 72h; EXAMPLE 5 Preparation of N-methyl-2- [1-[[5-methyl-3-(trifluoromethyl)-1H-pyrazol-1-yl]acetyl]-4-piperidinyl]-N-[(1R)-1-phenylethyl]-4-thiazolecarboxamide (Compound 70) Step A: Preparation of 1,1-dimethylethyl 4-[4-[[methyl [(1R)-1-phenylethyl]arrno]-carbonyl]-2-thiazolyl]-1-piperidinecarboxylate. 1-(1,1-Dimethylethyl)4-(4-carboxy-2-thiazolyl)-1-piperidinecarboxylate (i.e. the product of Example 1, Step B) (6.86 g, 21.96 mmol) was suspended in 30 mL of dry acetonitrile and treated with triethylamine (6.12 mL, 43.92 mmol) to give a homogeneous solution. To this was added O-benzotriazol-1-yl-N,N,N',N'-tetramethyluronium hexafluorophosphate (9.16 g, 24.16 mmol) followed by (alphaR)-N-alpha-dimethylbenzene-methanamine (3.19 mL, 21.96 mmol). The reaction mixture was stirred at ambient temperature for 3 days, concentrated under reduced pressure, diluted with ethyl acetate, washed with 1 N aqueous hydrochloric acid, saturated aqueous sodium bicarbonate solution and brine, dried over magnesium sulfate and concentrated under reduced pressure to give a dark oil. Purification by silica gel chromatography using 25-100 % ethyl acetate in hexanes as eluant gave 9.12 g of the title compound as an oil.1H NMR (CDCl3) delta 1.46 (s, 9H), 1.6-1.8 (m, 5H), 2.0-2.2 (m, 2H), 2.7-3.0 (m, 5H), 3.15 (m, IH), 4.15 (m, 2H), 5.7-6.2 (m, IH), 7.25-7.45 (m, 5H), 7.81 (s, IH).
  • 79
  • [ 5933-40-4 ]
  • (M)-2-bromomethyl-1-(2-methoxy-4,6-dimethylphenyl)naphthalene [ No CAS ]
  • [ 794469-18-4 ]
  • 80
  • [ 5933-40-4 ]
  • (P)-2-bromomethyl-1-(2-methoxy-4,6-dimethylphenyl)naphthalene [ No CAS ]
  • [ 794469-18-4 ]
  • 81
  • [ 1564-64-3 ]
  • [ 5933-40-4 ]
  • [ 944548-46-3 ]
  • [ 10557-01-4 ]
  • [ 120-12-7 ]
  • 82
  • [ 523-27-3 ]
  • [ 5933-40-4 ]
  • [ 944548-46-3 ]
  • 9,10-di-(N-methyl-N-(R)-α-methylbenzylamino)anthracene [ No CAS ]
  • [ 10557-01-4 ]
  • 83
  • [ 14990-09-1 ]
  • [ 5933-40-4 ]
  • tert-butyl (αR)-3-[N-methyl-N-(α-methylbenzyl)amino]-3-phenylpropanoate [ No CAS ]
  • 84
  • [ 79218-15-8 ]
  • [ 5933-40-4 ]
  • [ 946065-00-5 ]
  • 85
  • [ 5933-40-4 ]
  • [ 13600-42-5 ]
  • (R)-(+)-2-chloro-6-[methyl-(1-phenyl-ethyl)-amino]-4-trifluoromethyl-nicotinonitrile [ No CAS ]
YieldReaction ConditionsOperation in experiment
96.16% With potassium carbonate; In DMF (N,N-dimethyl-formamide); at 91℃; for 1h; The starting materials, 2, 6-dichloro-4-trifluoromethyl-nicotinonitrile (5. 0g, 21mmol) and (R)- (+)-N, alpha-dimethyl benzylamine (2.6 g, 19mmol) were dissolved in 85ml of dry DMF, thenK2CO3 (5.0g) was suspended in the mixture, the reaction was stirred at91 C for 1 h, it was checked by MS. When it was completed, theK2CO3 was filtered out, the solvent was removed to get an oily liquid, it was on vacuum overnight, the crude product was a slight yellow solid. The crude product was washed with hot hexane to yield a pure product (6.16g, 96.16%). MS: 340.1(M+1 for C16H13ClN3F3). LCMS: C-18 Column (25% H20/ 75% CH3CN), Ret. Time: 1.99 min Purity: 99.1%
  • 86
  • [ 5933-40-4 ]
  • tert-butyl (αR)-2-(1'-hydroxybenzyl)-3-[N-methyl-N-(α-methylbenzyl)amino]-3-phenylpropanoate [ No CAS ]
  • 87
  • [ 5933-40-4 ]
  • tert-butyl (2S,3S,1'S,αR)-2-(1'-hydroxy-2'-methyl)propyl-3-[N-methyl-N-(α-methylbenzyl)amino]-3-phenylpropanoate [ No CAS ]
  • 88
  • [ 5933-40-4 ]
  • tert-butyl (αR)-2-(1'-hydroxy-2'-methyl)propyl-3-[N-methyl-N-(α-methylbenzyl)amino]-3-phenylpropanoate [ No CAS ]
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5933-40-4 ]

Aryls

Chemical Structure| 17480-69-2

[ 17480-69-2 ]

S-(-)-N-Benzyl-1-phenylethylamine

Similarity: 0.97

Chemical Structure| 38235-77-7

[ 38235-77-7 ]

(R)-N-Benzyl-1-phenylethanamine

Similarity: 0.97

Chemical Structure| 1096105-18-8

[ 1096105-18-8 ]

(R)-N-Methyl-1-phenylethanamine hydrochloride

Similarity: 0.97

Chemical Structure| 15297-33-3

[ 15297-33-3 ]

(R)-N-Methyl-1-(naphthalen-1-yl)ethanamine

Similarity: 0.94

Chemical Structure| 163831-65-0

[ 163831-65-0 ]

(R)-N-Benzyl-1-(naphthalen-1-yl)ethanamine hydrochloride

Similarity: 0.89

Amines

Chemical Structure| 17480-69-2

[ 17480-69-2 ]

S-(-)-N-Benzyl-1-phenylethylamine

Similarity: 0.97

Chemical Structure| 38235-77-7

[ 38235-77-7 ]

(R)-N-Benzyl-1-phenylethanamine

Similarity: 0.97

Chemical Structure| 1096105-18-8

[ 1096105-18-8 ]

(R)-N-Methyl-1-phenylethanamine hydrochloride

Similarity: 0.97

Chemical Structure| 15297-33-3

[ 15297-33-3 ]

(R)-N-Methyl-1-(naphthalen-1-yl)ethanamine

Similarity: 0.94

Chemical Structure| 56862-34-1

[ 56862-34-1 ]

N-(1-Phenylethyl)prop-2-yn-1-amine

Similarity: 0.89